TABLE 4.
Clinical application of PFCs.
| Type of PFCs | Application | Disease | References |
|---|---|---|---|
| Dodecafluoropentane | Neuroprotection | Stroke | Culp et al. (2019) |
| Perfluorochemical plus O 2 | Whole-pancreas transplantation | Pancreas transplantation | Matsumoto et al. (2000) |
| Perfluorochemical plus O 2 | Pancreas transplantation | Pancreas transplantation | Toyama et al. (2003) |
| Perflubutane | Computed Tomography (CT) and Ultrasonography (US) imaging | Hyper vascular hepatocellular carcinoma | Numata et al. (2012) |
| Perfluorobutane microbubbles | US | colorectal liver metastases | Takahashi et al. (2012) |
| Perflubutane microbubble | US | focal liver lesions | Moriyasu and Itoh (2009) |
| liquid perfluorocarbon pads | 3-T MRI | choice of optimal fat suppression method | Maehara et al. (2014) |
| Perflubutane microbubble | US | prostate cancer | Uemura et al. (2013) |
| Perfluorocarbon | fluorine-19 MRI | colorectal adenocarcinoma | Ahrens et al. (2014) |
| Perfluorocarbon | Following intratracheal (IT) delivery of PFC NP to locally deliver PFC NP in high concentrations into lung cancers | Lung cancer | Wu et al. (2018) |